TWI911391B - 含有麥角硒因的covid 19治療或預防藥 - Google Patents
含有麥角硒因的covid 19治療或預防藥Info
- Publication number
- TWI911391B TWI911391B TW111106368A TW111106368A TWI911391B TW I911391 B TWI911391 B TW I911391B TW 111106368 A TW111106368 A TW 111106368A TW 111106368 A TW111106368 A TW 111106368A TW I911391 B TWI911391 B TW I911391B
- Authority
- TW
- Taiwan
- Prior art keywords
- protease
- ergot
- papain
- sars
- pro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-026585 | 2021-02-22 | ||
| JP2021026585 | 2021-02-22 | ||
| JP2021-106076 | 2021-06-25 | ||
| JP2021106076 | 2021-06-25 | ||
| JP2021-165803 | 2021-10-07 | ||
| JP2021165803 | 2021-10-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202302093A TW202302093A (zh) | 2023-01-16 |
| TWI911391B true TWI911391B (zh) | 2026-01-11 |
Family
ID=82931986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111106368A TWI911391B (zh) | 2021-02-22 | 2022-02-22 | 含有麥角硒因的covid 19治療或預防藥 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250352517A1 (https=) |
| JP (1) | JP7837513B2 (https=) |
| TW (1) | TWI911391B (https=) |
| WO (1) | WO2022177029A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115737675B (zh) * | 2022-11-28 | 2024-03-08 | 安徽农业大学 | 氧化型硒代硫酸钠的制备及其在治疗冠状病毒感染中的应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019173159A1 (en) * | 2018-03-05 | 2019-09-12 | Mironova Innovations, Llc | Ergothioneine compositions and methods for maintaining and/or increasing vitamin c levels in cells and organisms |
-
2022
- 2022-02-22 US US18/278,142 patent/US20250352517A1/en active Pending
- 2022-02-22 JP JP2023500976A patent/JP7837513B2/ja active Active
- 2022-02-22 WO PCT/JP2022/007397 patent/WO2022177029A1/ja not_active Ceased
- 2022-02-22 TW TW111106368A patent/TWI911391B/zh active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019173159A1 (en) * | 2018-03-05 | 2019-09-12 | Mironova Innovations, Llc | Ergothioneine compositions and methods for maintaining and/or increasing vitamin c levels in cells and organisms |
Non-Patent Citations (2)
| Title |
|---|
| 期刊 Seale, Lucia A et al A role for selenium-dependent GPX1 in SARS-CoV-2 virulence The American Journal of Clinical Nutrition Volume 112, Issue 2 2020/08 p447–448 * |
| 期刊 Yamashita, Yumiko et al Identification of a Novel Selenium-containing Compound, Selenoneine, as the Predominant Chemical Form of Organic Selenium in the Blood of Bluefin Tuna Journal of Biological Chemistry Volume 285, Issue 24 2010/06 p18134-18138 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202302093A (zh) | 2023-01-16 |
| JP7837513B2 (ja) | 2026-03-31 |
| US20250352517A1 (en) | 2025-11-20 |
| WO2022177029A1 (ja) | 2022-08-25 |
| JPWO2022177029A1 (https=) | 2022-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rehman et al. | Oxidative stress in poultry: lessons from the viral infections | |
| Skinner-Adams et al. | Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds | |
| MX2008015259A (es) | Composicion farmaceutica para el tratamiento de infecciones virales y/o enfermedades tumorales por medio de la inhibicion del plegamiento proteico y la degradacion proteica. | |
| Lu et al. | Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells | |
| KR20160030935A (ko) | 디펩티딜 펩티다아제 ⅳ (dppⅳ) 저해 펩티드 화합물, 그것을 함유하는 조성물, 및 그 제조 방법 | |
| TWI911391B (zh) | 含有麥角硒因的covid 19治療或預防藥 | |
| WO2009035169A1 (ja) | 血圧上昇抑制作用を有するぺプチド | |
| CN113087773A (zh) | 一种具有降血糖和抗氧化功能的牦牛骨肽及其制备方法 | |
| Cao et al. | A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from Wuyi rock tea residue: Preparation, identification, and its potential molecular mechanism | |
| WO2008047663A1 (en) | Activity enhancer for detoxifying enzyme | |
| KR102926860B1 (ko) | 육모제, 및 이를 포함하는 음식품 | |
| CN106038695B (zh) | 鳄梨萃取物、鳄梨醇b及(2r,4r)-1,2,4-三羟基十七碳-16-炔的用途,以及包含鳄梨萃取物的保健食品 | |
| JP5220415B2 (ja) | 老人性貧血を防止又は治療するためのアミノ酸組成物 | |
| CN102821783A (zh) | 治疗hiv感染及aids相关症状的融合蛋白及方法 | |
| JP2008214232A (ja) | コラーゲン合成促進剤 | |
| CN116178494A (zh) | 一种解酒多肽 | |
| JP2024070649A (ja) | 筋萎縮抑制剤及び筋萎縮防止用組成物 | |
| Takahashi et al. | Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products | |
| CN112457374A (zh) | 具有血管紧张素转化酶抑制活性的单环刺螠多肽及其应用 | |
| JPWO2009066562A1 (ja) | 赤血球系幹細胞の分化促進剤及び/又は増殖促進剤、並びに老人性貧血を防止又は治療するためのメチオニンの使用及びメチオニンを含む組成物 | |
| KR20180014360A (ko) | 만성 염증성 장 질환 치료용 또는 장 기능 개선용 조성물 | |
| JP3122092B2 (ja) | アンジオテンシン変換酵素阻害性ペプチド | |
| US12318421B2 (en) | Mung bean hull extract with antiviral effect and extraction method thereof | |
| CN119192281B (zh) | 一种核桃蛋白源血管紧张素转化酶富硒肽及其制备方法和在降血压中的应用 | |
| KR20220014503A (ko) | 해삼 동충하초 배양액 및 이의 제조방법 |